home / stock / cgtx / cgtx short
Short Information | Cognition Therapeutics Inc. (NASDAQ:CGTX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 842,116 |
Total Actual Volume | 5,795,597 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 42,106 |
Average Short Percentage | 18.97% |
Is there a CGTX Short Squeeze or Breakout about to happen?
See the CGTX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-26-2024 | $2.11 | $2.37 | $2.535 | $2.1 | 2,486,959 | 155,574 | 6.26% |
07-25-2024 | $1.82 | $2.1 | $2.14 | $1.8 | 536,837 | 107,367 | 20% |
07-24-2024 | $1.81 | $1.84 | $1.84 | $1.77 | 112,286 | 15,540 | 13.84% |
07-23-2024 | $1.9 | $1.79 | $1.9 | $1.709 | 408,393 | 49,958 | 12.23% |
07-22-2024 | $1.88 | $1.88 | $1.92 | $1.8 | 186,372 | 20,334 | 10.91% |
07-19-2024 | $1.98 | $1.84 | $1.98 | $1.805 | 154,847 | 30,308 | 19.57% |
07-18-2024 | $1.93 | $1.94 | $1.98 | $1.92 | 57,241 | 8,929 | 15.6% |
07-17-2024 | $2.05 | $1.92 | $2.05 | $1.89 | 111,796 | 22,956 | 20.53% |
07-16-2024 | $1.94 | $1.98 | $2.01 | $1.89 | 62,342 | 7,811 | 12.53% |
07-15-2024 | $2.01 | $1.92 | $2.09 | $1.9 | 89,901 | 10,023 | 11.15% |
07-12-2024 | $1.87 | $1.98 | $1.99 | $1.85 | 72,450 | 18,615 | 25.69% |
07-11-2024 | $1.88 | $1.83 | $1.92 | $1.83 | 95,021 | 21,604 | 22.74% |
07-10-2024 | $2.07 | $1.86 | $2.0781 | $1.86 | 166,415 | 18,384 | 11.05% |
07-09-2024 | $1.92 | $2.06 | $2.12 | $1.92 | 157,798 | 36,095 | 22.87% |
07-08-2024 | $1.93 | $1.88 | $1.97 | $1.87 | 70,857 | 10,904 | 15.39% |
07-05-2024 | $1.8 | $1.91 | $2 | $1.8 | 124,305 | 55,022 | 44.26% |
07-03-2024 | $1.8 | $1.77 | $1.8893 | $1.75 | 88,536 | 29,454 | 33.27% |
07-02-2024 | $1.75 | $1.82 | $2.04 | $1.7297 | 660,397 | 198,926 | 30.12% |
07-01-2024 | $1.68 | $1.67 | $1.7599 | $1.65 | 79,944 | 16,497 | 20.64% |
06-28-2024 | $1.7 | $1.66 | $1.705 | $1.64 | 72,900 | 7,815 | 10.72% |
News, Short Squeeze, Breakout and More Instantly...
Cognition Therapeutics Inc. Company Name:
CGTX Stock Symbol:
NASDAQ Market:
Cognition Therapeutics Inc. Website:
PURCHASE, N.Y., July 26, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders will host an investor webcast on Monday, July 29, 2024...
PURCHASE, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, today announced that abstracts summarizing clinical e...
Completed enrollment for Phase 2 SEQUEL trial in mild-to-moderate Alzheimer’s disease (AD); topline results expected 2Q 2023 SHINE (AD) trial currently enrolling patients with first patient in Spain enrolled. Expect full enrollment by end of 2023 Received FDA clearance to...